← Back to Search

Suture

Vicryl absorbable suture for Interrupted Subdermal Suture

N/A
Waitlist Available
Research Sponsored by University of California, Davis
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 3 months following procedure
Awards & highlights

Study Summary

This trial is investigating the cosmetic appeal of scars when surgical deep sutures are spaced one centimeter apart versus two centimeters apart.

Eligible Conditions
  • Interrupted Subdermal Suture

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~3 months following procedure
This trial's timeline: 3 weeks for screening, Varies for treatment, and 3 months following procedure for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Scar Assessment
Secondary outcome measures
Erythema
Width of Scar

Trial Design

2Treatment groups
Experimental Treatment
Group I: Vicryl absorbable suture placed 2 cm apartExperimental Treatment1 Intervention
Wound closed with sutures spaced 2 centimeters apart will be treated in a simple, interrupted subdermal suture pattern
Group II: Vicryl absorbable suture placed 1 cm apartExperimental Treatment1 Intervention
Wound closed with sutures spaced 1 centimeter apart will be treated in a simple, interrupted subdermal suture pattern
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Vicryl absorbable suture
2017
N/A
~50

Find a Location

Who is running the clinical trial?

University of California, DavisLead Sponsor
919 Previous Clinical Trials
4,720,866 Total Patients Enrolled
~6 spots leftby Jun 2025